All articles by Liam Stoker

1. GSK to acquire vaccine technology company Okairos

   UK-based pharmaceutical major GlaxoSmithKline (GSK) has purchased Switzerland-based vaccine company Okairos in a deal worth €250m. GSK will now look…
   Read More…

   29 May
2. US Supreme Court backs Amgen shareholders to sue company as a group

   The US Supreme Court has backed Amgen shareholders to sue the company as a group without having to demonstrate that…
   Read More…

   27 Feb
3. Pharmaceutical science – catching up with Armstrong’s doping Peloton

   Lance Armstrong’s career was blighted by suspicion, which has been shown to have been justified. Image courtesy of Benutzer Hase…
   Read More…

   17 Oct
4. Abbott hepatitis C treatment suppresses virus

   Abbott’s interferon-free investigational regimen for the treatment of hepatitis C has successfully suppressed the virus during a Phase IIb study….
   Read More…

   17 Oct
5. US hospitals warned over Medicare fraud

   US authorities have warned against hospitals defrauding the Medicare system, citing "troubling indications" that doctors may be using electronic records…
   Read More…

   25 Sep
6. Sanofi multiple sclerosis treatment wins US approval

   Sanofi has won US Food and Drug Administration approval for its multiple sclerosis medication Aubagio. Clinical trials have demonstrated that,…
   Read More…

   13 Sep
7. Sanofi dengue fever vaccine shows potential

   A vaccine for dengue fever developed by Sanofi has shown the potential to protect against three of the four disease…
   Read More…

   12 Sep
8. Indian Supreme Court begins final hearing on Glivec patent case

   Novartis has taken to the stand in India’s Supreme Court, arguing for patent protection for its cancer drug Glivec in…
   Read More…

   11 Sep
9. UK health bodies alerted after latest anthrax death

   The UK Department of Health has issued a warning to the nation’s National Health Service (NHS) following the death of…
   Read More…

   10 Sep
10. AstraZeneca pulls obesity drug after allergic reaction

    AstraZeneca has decided to discontinue the development of obesity drug AZD2820 after a patient given the drug as part of…
    Read More…

    10 Sep